BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Yakult Honsha Co., Ltd. 

1-19 Higashi Shimbashi 1-chome
Minato-ku
Tokyo      Japan
Phone: 03-3574-8960 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Suppliers






 Company News
AEterna Zentaris (AEZS): Partner Yakult Honsha Initiates Phase 1 Trial in Multiple Myeloma With Perifosine in Japan 6/28/2012 11:31:47 AM
AEterna Zentaris (AEZS) Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in Japan 1/3/2012 9:28:16 AM
Proacta Inc. and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement 8/3/2011 10:56:48 AM
AEterna Zentaris (AEZS) and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for Lead Oncology Compound, Perifosine, for the Japanese Market 3/9/2011 7:44:46 AM
Proacta Inc. and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 2/22/2011 6:52:47 AM
Celsion Corporation (CLN) and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer 10/27/2009 10:20:14 AM
Celsion Corporation (CLN) to Hold Conference Call to Discuss Its Announced Japan License Agreement for Thermodox(R) with Yakult Honsha 12/17/2008 9:46:38 AM
Celsion Corporation (CLN) Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox(R); Agreement Includes $20.5 Million in License Fees 12/16/2008 2:09:19 AM
Yakult Honsha to Commence ThermoDox(R) Development Program in Japan 8/18/2008 8:51:16 AM
GPC Biotech AG (GPCG.DE) Announces Partnering Agreement for Satraplatin for Japan with Yakult Honsha; Upfront Payment 1.2B Yen ($10M) to GPC Biotech 6/25/2007 10:07:24 AM
12